The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

StemCells, Inc. - Research and Development of Cell-based Therapeutics for the Treatment of Central Nervous System Disorders

SNNLive spoke with Ian Massey, President and CEO of StemCells, Inc. (NASDAQ: STEM) at the Source Capital 2016 Disruptive Growth & Healthcare Conference in New York City, NY.

Share With

Monday, February 29, 2016

   

© 2017 Stock News Now